Amber D Bowler

MYELOID NEOPLASIA shRNA library screening identi fi es nucleocytoplasmic transport as a mediator of BCR-ABL 1 kinase-independent resistance

M. Deininger, A. Chenchik, K. Ullman, 2015 .

Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 Mutants.

J. Cayuela, P. Szankasi, B. Druker, 2019, Cancer cell.

shRNA library screening identifies nucleocytoplasmic transport as a mediator of BCR-ABL1 kinase-independent resistance.

M. Deininger, A. Chenchik, K. Ullman, 2015, Blood.

β-Catenin is required for intrinsic but not extrinsic BCR-ABL1 kinase-independent resistance to tyrosine kinase inhibitors in chronic myeloid leukemia

M. Deininger, T. O'hare, David J Anderson, 2015, Leukemia.

Neutrophils suppress tumor‐infiltrating T cells in colon cancer via matrix metalloproteinase‐mediated activation of TGFβ

M. Delorenzi, G. Coukos, C. Sempoux, 2019, EMBO molecular medicine.

MS4A3 Promotes Differentiation in Chronic Myeloid Leukemia by Enhancing Common β Chain Cytokine Receptor Endocytosis.

Kristofer C. Berrett, S. Varambally, J. Radich, 2021, Blood.

MS4A3 Improves Imatinib Response and Survival in BCR-ABL1 Primary TKI Resistance and in Blastic Transformation of Chronic Myeloid Leukemia

S. McWeeney, D. Stirewalt, B. Druker, 2015 .

Bcl-xL targeting eliminates ageing tumor-promoting neutrophils and inhibits lung tumor growth.

Amber D Bowler, Etienne Meylan, Nadine Fournier, 2023, EMBO molecular medicine.